Massive hyperplasia of marginal zone B-cells with clear cytoplasm in the lymph node: a case report

Masaru Kojima1, Shigeo Nakamura, Hiroshi Tanaka

  • 1Department of Pathology and Clinical Laboratories, Gunma Cancer Center Hospital, Ohta, Japan. mkojima@gunma-cc.jp

Insights

Systemic bacterial infection caused enlarged axillary lymph nodes with proliferating marginal zone B-cells. This benign condition requires differentiation from B-cell lymphomas.

Area of Science:

  • Hematology
  • Immunology
  • Pathology

Background:

  • Marginal zone B-cells are key players in immune responses.
  • Understanding B-cell hyperplasia is crucial for diagnosing lymphoproliferative disorders.

Observation:

  • An enlarged axillary lymph node exhibited proliferating marginal zone B-cells in nodular and aggregate patterns.
  • These cells infiltrated surrounding fatty tissue, displaying specific morphological and immunophenotypical characteristics.

Findings:

  • Immunohistochemistry revealed CD20+, CD79a+, Bcl-2+, sIgD-, CD5-, CD10-, CD21-, CD23-, CD45RO-, Bcl-6-, cyclin D+.
  • A subset of cells tested positive for sIgM and CD43.
  • Polymerase chain reaction and immunohistochemistry confirmed the polytypic nature of the cells, indicating a reactive process.

Implications:

  • Systemic bacterial infection is identified as the likely cause of this marginal zone B-cell hyperplasia.
  • Distinguishing this reactive hyperplasia from low-grade B-cell lymphomas, especially nodal marginal zone B-cell lymphoma, is essential for accurate diagnosis and patient management.